Prognosis
Pfizer’s Cape Town Deal to Produce 100 Million Vaccine Doses for Africa
- Cape Town facility to make more than 100 million doses a year
- Africa is least-vaccinated continent, underscoring inequity
Photographer: Francisco Seco/AP Photo
This article is for subscribers only.
Sign up to our Next Africa newsletter and follow Bloomberg Africa on Twitter
Pfizer Inc. said it reached an agreement to start production of its Covid-19 vaccine at a facility in Cape Town in an effort to deliver more than 100 million doses annually to African nations.